manufacturers of glp 1 drugs GLP-1 Safety Check GLP-1 Costs Explained: Managing Coverage

This could lead to higher drug prices for patients and healthcare systems

This encouraged scientists to begin investigating whether targeting the central nervous system could provide an effective strategy for weight loss (Capozzi, DiMarchi, Tschpp)

Clinical Trial Evidence: Landmark cardiovascular outcome trials (CVOTs) like the SELECT trial (for semaglutide) have shown a significant reduction in major adverse cardiovascular events (MACE), including heart attack, stroke, and cardiovascular death

FidanYaylal G., Dodurga Y., Seme M., and Elmas L., Antidiabetic Exendin4 Activates Apoptotic Pathway and Inhibits Growth of Breast Cancer Cells, Tumour Biology 37 (2016): 26472653

Employers can stay ahead of the GLP-1 curve by proactively evaluating coverage strategies and vendors, monitoring utilization trends, and leveraging data-driven insights to manage costs effectively in 2025 and beyond.

Thats why Found provides a comprehensive set of prescription medications in addition to behavior change support and access to clinicians trained in obesity medicine